首页> 外文期刊>The American Journal of Human Genetics >Cathepsin D deficiency is associated with a human neurodegenerative disorder
【24h】

Cathepsin D deficiency is associated with a human neurodegenerative disorder

机译:组织蛋白酶D缺乏与人类神经退行性疾病有关

获取原文
获取原文并翻译 | 示例
           

摘要

Cathepsin D is a ubiquitously expressed lysosomal protease that is involved in proteolytic degradation, cell invasion, and apoptosis. In mice and sheep, cathepsin D deficiency is known to cause a fatal neurodegenerative disease. Here, we report a novel disorder in a child with early blindness and progressive psychomotor disability. Two missense mutations in the CTSD gene, F229I and W383C, were identified and were found to cause markedly reduced proteolytic activity and a diminished amount of cathepsin D in patient fibroblasts. Expression of cathepsin D mutants in cathepsin D-/- mouse fibroblasts revealed disturbed posttranslational processing and intracellular targeting for W383C and diminished maximal enzyme velocity for F229I. The structural effects of cathepsin D mutants were estimated by computer modeling, which suggested larger structural alterations for W383C than for F229I. Our studies broaden the group of human neurodegenerative disorders and add new insight into the cellular functions of human cathepsin D.
机译:组织蛋白酶D是一种普遍表达的溶酶体蛋白酶,参与蛋白水解降解,细胞侵袭和凋亡。在小鼠和绵羊中,组织蛋白酶D缺乏会导致致命的神经退行性疾病。在这里,我们报告患有早期失明和进行性精神运动障碍的儿童的新型疾病。 CTSD基因中的两个错义突变F229I和W383C被发现,并发现它们导致患者成纤维细胞的蛋白水解活性显着降低,组织蛋白酶D减少。组织蛋白酶D突变体在组织蛋白酶D-/-小鼠成纤维细胞中的表达表明,W383C的翻译后加工和细胞内靶向受到干扰,F229I的最大酶速度降低。组织蛋白酶D突变体的结构效应是通过计算机建模估算的,这表明W383C的结构改变比F229I更大。我们的研究拓宽了人类神经退行性疾病的范围,并为人类组织蛋白酶D的细胞功能增添了新见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号